Buy Pain Therapeutics Stock | PTIE Stock Price & Latest News | Public
PTIE

Pain Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About PTIE

    Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$255,51M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.68
    1 Year Low$1.51
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app